aclidinium vs olodaterol
Side-by-side comparison of aclidinium and olodaterol Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Tudorza Pressair
Striverdi Respimat
Duaklir Pressair is a combination medicine used to help people with COPD breathe better. It contains two medicines that open up the airways in your lungs.
Striverdi Respimat is a medicine that helps people with COPD breathe easier. It contains olodaterol, which is a long-acting beta-2 agonist (LABA).
Duaklir Pressair is used to treat chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. This medicine helps to open the airways and make it easier to breathe for people with COPD.
Striverdi Respimat is used long-term to treat COPD, including chronic bronchitis and emphysema. It helps to open up the airways in your lungs, making it easier to breathe. This medicine is not for sudden COPD symptoms or for asthma.
Duaklir Pressair contains two medicines that work in different ways. One medicine relaxes the muscles around your airways, opening them up. The other medicine prevents the muscles from tightening.
Olodaterol is a LABA. It works by relaxing the muscles around your airways. This helps to open them up so air can flow in and out of your lungs more easily.
- • Upper respiratory infection
- • Headache
- • Back pain
- • Common cold symptoms
- • Cough
- • Back pain
- Difficulty breathing 1,869
- Inhaler not working correctly 1,281
- Skipped a dose of medicine 1,017
- Asthma 814
- Chronic obstructive pulmonary disease (COPD) 764
No adverse event reports.
LABAs, such as formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, increase the risk of asthma-related death. Duaklir Pressair is not for asthma. Do not use Duaklir Pressair if you are allergic to milk proteins or any of the ingredients in it. Tell your doctor if you have heart problems, glaucoma, trouble urinating, diabetes, or seizures.
LABAs like olodaterol can raise the risk of asthma-related death if used alone to treat asthma. Striverdi Respimat is not for asthma. Using too much Striverdi Respimat can cause serious heart problems and may be fatal. If you have a bad reaction, like swelling or trouble breathing, stop using Striverdi Respimat and get medical help right away.
It is not known if Duaklir Pressair will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if this medicine passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking Duaklir Pressair.
Tell your doctor if you are pregnant or plan to become pregnant. Striverdi Respimat should only be used during pregnancy if the benefit outweighs the risk to the baby. It is not known if Striverdi Respimat passes into breast milk.
Also Compare — Nearby Drugs
Compare aclidinium with
Compare olodaterol with
How to Read This aclidinium vs olodaterol Comparison
aclidinium is classified in the Long-Acting Muscarinic Antagonist (LAMA) drug class, while olodaterol sits within the Long-Acting Beta-2 Agonist (LABA) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, aclidinium has 5,745 submissions while olodaterol has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between aclidinium and olodaterol — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.